Exosomal delivery of RPS3 protein may induce chemoresistance phenotypes from cisplatin-resistant gastric cancer cells to sensitive cancer cells by regulating the PI3K-Akt-cofilin-1 signaling pathway. Here, CFL1 is linked to cancer.